Moexipril Hydrochloride/hydrochlorothiazide
NDC Package 16252-613-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Moexipril Hydrochloride/hydrochlorothiazide is a . Marketed by Cobalt Laboratories, this product is identified by NDC 16252-613 and is authorized under FDA application NDA020729.

Identification & Billing

NDC Package Code
16252-613-01
Package Description
100 TABLET, FILM COATED in 1 BOTTLE
Product Code
16252-613
11-Digit Billing Format
16252061301

Clinical Specifications

Proprietary Name
Moexipril Hydrochloride/hydrochlorothiazide
Dosage Form
-

Regulatory & Marketing

Labeler Name
Cobalt Laboratories
FDA Application #
NDA020729
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-15-2007
End Marketing Date
03-31-2013
Listing Expiration
03-31-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 16252-613-01 identifies a specific commercial package of 100 tablet, film coated in 1 bottle of Moexipril Hydrochloride/hydrochlorothiazide, labeled by Cobalt Laboratories. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cobalt Laboratories on March 15, 2007. The current certification is valid through March 31, 2013.

How is this Cobalt Laboratories product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 16252061301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
16252-613-01
11-Digit CMS (5-4-2)
16252-0613-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.